Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model

This publication has 27 references indexed in Scilit:

• Role of Human Hypoxanthine Guanine Phosphoribosyltransferase in Activation of the Antiviral Agent T-705 (Favipiravir)
  Molecular Pharmacology, 2013
• The Ambiguous Base-Pairing and High Substrate Efficiency of T-705 (Favipiravir) Ribofuranosyl 5′-Triphosphate towards Influenza A Virus Polymerase
  PLOS ONE, 2013
• T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In Vitro
  Journal of Virology, 2013
• Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques
  Proceedings of the National Academy of Sciences, 2012
• Ebola haemorrhagic fever
  Published by Elsevier ,2010
• Intracellular metabolism of favipiravir (T-705) in uninfected and influenza A (H5N1) virus-infected cells
  Journal of Antimicrobial Chemotherapy, 2009
• Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents
  Antiviral Research, 2008
• In Vitro and In Vivo Activities of T-705 against Arenavirus and Bunyavirus Infections
  Antimicrobial Agents and Chemotherapy, 2007
• Effective Post-Exposure Treatment of Ebola Infection
  PLoS Pathogens, 2007
• Lassa Fever
  New England Journal of Medicine, 1986